VIRIOM
Viriom Inc. is a development and commercial stage biotech company developing novel and affordable medicines against life threatening infections such as HIV and HBV. The company has an exclusive worldwide license to its phase 3 and commercial stage lead compounds (Elpida/elsulfavirine and VM1500A) from Hoffmann-La Roche and has developed proprietary drug candidates VM2500, VM3500 LAI formulations and combinations with cell, vaccine and antibody drugs for treatment, prophylaxis and cure of HIV. Viriom makes a breakthrough in treating, preventing and curing HIV and chronic HBV infections worldwide.
VIRIOM
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.viriom.com
Total Employee:
251+
Status:
Active
Contact:
+1-858-7944860
Email Addresses:
[email protected]
Total Funding:
35.41 M USD
Technology used in webpage:
Squarespace Hosted
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EnBiotix
EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Investors List
Pharmstandard
Pharmstandard investment in Convertible Note - Viriom
Torrey Pines Investment
Torrey Pines Investment investment in Convertible Note - Viriom
ChemRar Ltd
ChemRar Ltd investment in Convertible Note - Viriom
Skolkovo Foundation
Skolkovo Foundation investment in Convertible Note - Viriom
Torrey Pines Investment
Torrey Pines Investment investment in Convertible Note - Viriom
Torrey Pines Investment
Torrey Pines Investment investment in Convertible Note - Viriom
MIT RF
MIT RF investment in Seed Round - Viriom
ChemRar Ventures
ChemRar Ventures investment in Seed Round - Viriom
MIT RF
MIT RF investment in Non Equity Assistance - Viriom
ChemRar Ventures
ChemRar Ventures investment in Seed Round - Viriom
Official Site Inspections
http://www.viriom.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Viriom"
Viriom
Viriom Inc. is advancing a pipeline of effective and affordable treatments for diseases of global interest. With our network of partners, we are building a global drug development platform …See details»
Viriom - Org Chart, Teams, Culture & Jobs - The Org
View Viriom's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Who We Are — Viriom
Chinese Center for Disease Control and Prevention, National Center for AIDS/STD Control and Prevention. Clinical Virology.See details»
What We Do - Viriom
Viriom's flexible global access strategy allows the company to address multiple disease targets exemplified by our programs in viral hepatitis, HIV, COVID-19, and seasonal or pandemic influenza, along with an increasing emphasis on …See details»
Viriom - Crunchbase Company Profile & Funding
Viriom is a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections. View contacts for Viriom to access new leads and connect with decision-makers.See details»
Viriom Company Profile 2024: Valuation, Funding
Developer of a biotechnology platform intended to focus on pharmaceuticals for treating certain viruses.See details»
Viriom - Products, Competitors, Financials, Employees, …
Viriom Inc. is a biotechnology company developing treatments for infectious and malignant diseases, particularly blood-borne and respiratory viral diseases, as well as solid tumors.See details»
Viriom - Overview, News & Similar companies | ZoomInfo.com
Nov 20, 2023 · Viriom is developing and commerciali zing the most innovative and affordable solutions to radically expand global access to the best antiviral treatments. Viriom's broad, …See details»
Viriom Company Profile - Office Locations, Competitors, Revenue …
Viriom is a biotech company developing therapies and prevention treatments against HIV and hepatitis B virus. Its pipeline includes Elpida, a non-nucleoside reverse transcriptase inhibitor, …See details»
Viriom announces NIH/NIAID and Division of AIDS Collaboration …
SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Viriom Inc., a clinical stage antiviral company focused on HIV and viral hepatitis (San Diego, CA), is developing long-acting versions of its …See details»
Respiratory Viral Diseases — Viriom
Viriom supports the development of antiviral drugs for respiratory viruses, RNA polymerase and protease inhibitors for COVID19. Viriom has successfully launched the first Favipiravir-based drug in the world approved for the …See details»
Viriom's Single Pill Influenza Treatment Completes Critical Phase I ...
Nov 20, 2023 · With a robust network of partners, Viriom is building a global drug development platform targeting infectious and malignant diseases. The company focuses on blood-borne …See details»
Viriom partners with government org to create Zika treatments
Jan 6, 2017 · The develops antiviral drugs developer is collaborating with the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD) to help create …See details»
Pipeline - Viriom
Viral diseases comprise global threats to human health and Viriom responds by delivering safe, effective, easy to use and affordable treatments. Our advanced drug development platform …See details»
Viriom outlines plans for upcoming infectious disease trials
Dec 5, 2023 · Viriom plans to extend a Phase I trial investigating its influenza pill AV5124, according to chief science officer Dr David Pauza. The US-based company announced the …See details»
ChemDiv Helps Advance Viriom's Influenza Treatment to …
Dec 19, 2023 · Together, Viriom and ChemDiv showcase AV5124's potent suppression of diverse Influenza A and Influenza B viruses, including drug-resistant variants and highly pathogenic …See details»
Elpida (elsulfavirine) becomes the preferred first line therapy for ...
Feb 2, 2021 · Viriom is developing and commercializing the most innovative and affordable solutions to radically expand global access to the best antiviral treatments. Viriom's broad, …See details»
Viriom Expands Global Licensing Agreement With Roche For
Nov 20, 2013 · Viriom Ltd. is a ChemRar company involved in developing innovative antiviral drugs and combinations, treatment methods, and diagnostics. Viriom conducts scientific …See details»
Viriom Announces Initiation of Phase 2 Study Investigating Efficacy …
San Diego, CA, May 4th, 2020 – Viriom, Inc. (Viriom) announced today the initiation of a Phase 2a study investigating the efficacy of an intramuscular long-acting injectable nanoformulation of …See details»
Viriom Inc - Facebook
Viriom Inc. is a late-stage biotech company developing novel and affordable therapies against life threatening infections such as HIV.See details»